Expert Perspective Tumor Board

Virtual Tumor Board

Targeted Oncology presents Expert Perspective Virtual Tumor Board, a video editorial series featuring multi-disciplinary collaboration between professionals reviewing patient cases and discussing diagnoses, biomarker testing, and treatment strategies.


Clinical Cases in Hepatocellular Carcinoma

November 24th 2021

A panel of experts review three clinical cases of hepatocellular carcinoma, highlighting individualized treatment approaches and key clinical trial data used to guide therapy.

Case Analyses in Renal Cell Carcinoma

October 27th 2021

Key opinion leaders review clinical cases in renal cell carcinoma, focusing on recent advances, treatment options, and clinical trials impacting treatment.

Case Studies in Thyroid Cancer

September 24th 2021

Key opinion leaders review clinical cases in thyroid cancer, focusing on recent advances, treatment options, and clinical trials impacting clinical practice.

Triple-Negative Breast Cancer

May 18th 2021

Key opinion leaders review clinical cases in triple-negative breast cancer, focusing on recent advances, treatment options, and clinical trials impacting the treatment.

Case Studies in Myeloproliferative Neoplasms

April 30th 2021

Experts in MPN review clinical cases of in polycythemia vera, myelofibrosis, and essential thrombocythemia.

HER2-Positive Breast Cancer

April 30th 2021

Key opinion leaders review clinical cases in HER2-positive breast cancer, focusing on treatment options and clinical trials impacting treatment selection.

Relapsed/Refractory HER2+ Metastatic Breast Cancer

March 30th 2021

Experts in breast cancer review clinical cases, discuss individualized treatment options and key clinical trials.

Clinical Cases in Gastrointestinal Stromal Tumors

March 17th 2021

Experts review 3 clinical cases, discuss treatment options and relevant clinical trials in GIST.

Clinical Cases in Advanced Prostate Cancer

December 21st 2020

Experts in genitourinary cancer review 2 clinical cases and address major changes in the management of patients with castration-resistant prostate cancer.

Clinical Cases in Relapsed and Refractory DLBCL

October 28th 2020

Experts review clinical cases and best practices for managing relapsed/refractory DLBCL.